Skip to main content
SpringerLink
Log in

Epidemiology of Hypertension in Asia

  • Chapter
  • First Online:
Hypertension and Cardiovascular Disease in Asia

Part of the book series: Updates in Hypertension and Cardiovascular Protection ((UHCP))

Abstract

Asia is the largest and most populous continent, with roughly 60% of the total population in the world. It is divided into five regions, namely Middle East, East Asia, South Asia, Southeast Asia, and Central Asia. Asian countries of interest in this chapter would include Afghanistan, Armenia, Azerbaijan, Bahrain, Bangladesh, Bhutan, Brunei, Cambodia, China, Georgia, India, Indonesia, Iran, Iraq, Israel, Japan, Jordan, Kazakhstan, Kuwait, Kyrgyzstan, Laos, Lebanon, Malaysia, Maldives, Mongolia, Myanmar, Nepal, North/South Korea, Oman, Pakistan, Philippines, Qatar, Russia, Saudi Arabia, Singapore, Sri Lanka, Syria, Tajikistan, Thailand, Timor-Leste, Turkey, Turkmenistan, United Arab Emirates, Uzbekistan, Vietnam, and Yemen. Much of the literature reviewed would involve the countries in Southeast Asia (SEA) (e.g., Malaysia, Indonesia, Thailand, Singapore, Philippines, Vietnam, Laos, Cambodia, Myanmar, Brunei, East Timor), Japan, and countries in the middle East. This chapter discusses the prevalence, incidence, and risk factors of hypertension across the Asian countries. It is important to highlight that the various literature reviewed here would have different definitions of hypertension and blood pressure control, as well as different methods in determining blood pressure measurements. Period of evaluation also varies from study to study. Caution must be exercised when interpreting the presented numbers, specifically for the prevalence and incidence data.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. WHO Website. https://www.who.int/news-room/fact-sheets/detail/h.

  2. World Health Organization. A global brief on hypertension. Geneva: World Health Organization; 2013.

    Google Scholar 

  3. Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015;386:801–12.

    Article  PubMed  Google Scholar 

  4. Mohammed Nawi A, Mohammad Z, Jetly K, Abd Razak MA, Ramli NS, Wan Ibadullah WAH, Ahmad N. The prevalence and risk factors of hypertension among the urban population in Southeast Asian countries: a systematic review and meta-analysis. Int J Hypertens. 2021;2021:6657003. https://doi.org/10.1155/2021/6657003.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kingue S, Ngoe CN, Menanga AP, Jingi AM, Noubiap JJN, Fesuh B, Nouedoui C, Andze G, Muna WFT. Prevalence and risk factors of hypertension in urban areas of cameroon: a nationwide population-based cross-sectional study. J Clin Hypertens. 2015;17:819–24.

    Article  Google Scholar 

  6. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/American Heart Association task. Hypertension. 2018;71(6):1269–324. https://doi.org/10.1161/HYP.0000000000000066.

    Article  CAS  PubMed  Google Scholar 

  7. Mancia G, De Backer G, Dominiczak A, et al. 2018 ESC/ESH guidelines for themanagement of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. https://doi.org/10.1097/HJH.0b013e3281fc975a.

    Article  CAS  PubMed  Google Scholar 

  8. Liu J. Highlights of the 2018 Chinese hypertension guidelines; 2020. p. 4–9.

    Google Scholar 

  9. Liu LS, Wu ZS, Wang JG, et al. 2018 Chinese guidelines for prevention and treatment of hypertension—a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16:182–245.

    Google Scholar 

  10. Lee H-Y, Shin J, Kim G-H, et al. 2018 Korean Society of Hypertension guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens. 2019;25:4–9.

    Article  Google Scholar 

  11. Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.

    Article  PubMed  Google Scholar 

  12. Ministry of Health Singapore. MOH clinical practice guidelines 1/2017: hypertension; 2017.

    Google Scholar 

  13. Ministry of Health Malaysia. Clinical practice guidelines management of hypertension; 2014.

    Google Scholar 

  14. Buranakitjaroen P, Sitthisook S, Wataganara T, et al. 2015 Thai hypertension guideline. 3; 2015.

    Google Scholar 

  15. Shah SN, Munjal YP, Kamath SA, et al. Indian guidelines on hypertension-IV (2019). J Hum Hypertens. 2020;34:745–58.

    Article  PubMed  Google Scholar 

  16. Saudi Hypertension Management Society. Saudi hypertension guidelines 2018. Saudi Com Heal Spec. 2018:47–8.

    Google Scholar 

  17. Ona DID, Jimeno CA, Jasul GV, et al. Executive summary of the 2020 clinical practice guidelines for the management of hypertension in the Philippines. J Clin Hypertens. 2021:1–14.

    Google Scholar 

  18. Chua YT, Wong WK, Gollamudi SPK, Cheang C, Leo H. Hypertension trends in Asia. Hypertens J. 2018;4

    Google Scholar 

  19. Zhou B, Bentham J, Di Cesare M, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017;389:37–55.

    Article  Google Scholar 

  20. World Health Organization. Noncommunicable diseases country profiles. 2018. https://www.who.int/nmh/publications/ncd-profiles-2018/en.

  21. WHO south east asia region. Blood pressure, take control. Reg Heal Forum, WHO South-East Asia Reg. 2013;17:1–83.

    Google Scholar 

  22. Tajikistan M of H and SP of P. Tajikistan Demographic and Health Survey; 2017.

    Google Scholar 

  23. Polupanov AG, Khalmatov AN, Altymysheva AT, Lunegova OS, Mirrakhimov AE, Sabirov IS, Kontsevaya AV, Dzhumagulova AS, Mirrakhimov EM. The prevalence of major cardiovascular risk factors in a rural population of the Chui region of Kyrgyzstan: the results of an epidemiological study. Anatol J Cardiol. 2020;24:183–91.

    PubMed  PubMed Central  Google Scholar 

  24. Supiyev A, Kossumov A, Utepova L, Nurgozhin T. Prevalence, awareness, treatment and control of arterial hypertension in Astana, Kazakhstan. A cross-sectional study. Public Health. 2015;129(7):948–53.

    Article  CAS  PubMed  Google Scholar 

  25. Aringazina A, Arkhipov V, Aringazina A. Burden of the cardiovascular diseases in Central Asia. Cent Asian J Glob Heal. 2018;7(1):321. https://doi.org/10.5195/cajgh.2018.321.

    Article  Google Scholar 

  26. Erina AM, Rotar OP, Solntsev VN, Shalnova SA, Deev AD, Baranova EI, Konradi AO, Boytsov SA, Shlyakhto EV. Epidemiology of arterial hypertension in Russian Federation—importance of choice of criteria of diagnosis. Kardiologiia. 2019;59:5–11.

    Article  CAS  PubMed  Google Scholar 

  27. Wang L, Li N, Heizhati M, et al. Prevalence, awareness, treatment, control, and related factors of hypertension among Tajik nomads living in Pamirs at high altitude. Int J Hypertens. 2020;2020:1–10. https://doi.org/10.1155/2020/5406485.

    Article  Google Scholar 

  28. Li X, Wu C, Lu J, Chen B, Li Y, Yang Y, Hu S, Li J. Cardiovascular risk factors in China: a nationwide population-based cohort study. Lancet Public Heal. 2020;5:e672–81.

    Article  Google Scholar 

  29. Ministry of Health Labour and Welfare Japan. The National Health and Nutrition Survey in Japan; 2016.

    Google Scholar 

  30. Potts H, Baatarsuren U, Myanganbayar M, et al. Hypertension prevalence and control in Ulaanbaatar, Mongolia. J Clin Hypertens. 2020;22:103–10.

    Article  Google Scholar 

  31. Li G, Wang H, Wang K, et al. Prevalence, awareness, treatment, control and risk factors related to hypertension among urban adults in Inner Mongolia 2014: differences between Mongolian and Han populations. BMC Public Health. 2016;16:1–10.

    Article  Google Scholar 

  32. Lee HH, Cho SMJ, Lee H, Baek J, Bae JH, Chung WJ, Kim HC. Korea heart disease fact sheet 2020: analysis of nationwide data. Korean Circ J. 2021;51:2–5.

    Article  Google Scholar 

  33. Report of Population Health Survey, Hong Kong. https://www.chp.gov.hk/files/pdf/dh_phs_2014_15_full_report_eng.pdf.

  34. Cheng HM, Lin HJ, Wang TD, Chen CH. Asian management of hypertension: current status, home blood pressure, and specific concerns in Taiwan. J Clin Hypertens. 2020;22:511–4.

    Article  Google Scholar 

  35. Khader Y, Batieha A, Jaddou H, Rawashdeh SI, El-Khateeb M, Hyassat D, Khader A, Ajlouni K. Hypertension in Jordan: prevalence, awareness, control, and its associated factors. Int J Hypertens. 2019;2019:3210617. https://doi.org/10.1155/2019/3210617.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ratnayake R, Rawashdeh F, Abualrub R, et al. Access to care and prevalence of hypertension and diabetes among Syrian refugees in Northern Jordan. JAMA Netw Open. 2020;3:1–13.

    Article  Google Scholar 

  37. Ibrahim M, Rizk H. Hypertension prevalence, awareness, treatment, and control in Egypt: results from the Egyptian National Hypertension Project (NHP). Hypertension. 1995;6:886–90.

    Article  Google Scholar 

  38. Yusufali AM, Khatib R, Islam S, Alhabib KF, Bahonar A, Swidan HM, Khammash U, Alshamiri MQ, Rangarajan SYS. Prevalence, awareness, treatment and control of hypertension in four Middle East countries. J Hypertens. 2017;35:1457–64.

    Article  CAS  PubMed  Google Scholar 

  39. Saeed AA, Al-hamdan NA, Bahnassy AA, Abdalla AM, Abbas MAF, Abuzaid LZ. Prevalence, awareness, treatment, and control of hypertension among Saudi adult population: a national survey. Int J Hypertens. 2011;2011:1–8.

    Article  Google Scholar 

  40. Alhabib KF, Batais MA, Almigbal TH, Alshamiri MQ, Altaradi H, Rangarajan S, Yusuf S. cardiovascular disease risk factors in the Saudi population: results from the Prospective Urban Rural Epidemiology study (PURE-Saudi). BMC Public Health. 2020;20:1–14.

    Article  Google Scholar 

  41. Bener A, Al-Suwaidi J, Al-Jaber K, Al-Marri S, Elbagi IE. Epidemiology of hypertension and its associated risk factors in the Qatari population. J Hum Hypertens. 2004;18:529–30.

    Article  CAS  PubMed  Google Scholar 

  42. Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016;34:1207–17.

    Article  CAS  Google Scholar 

  43. Abu-saad K, Chetrit A, Eilat-adar S, Alpert G, Atamna A, Gillon-keren M, Rogowski O, Ziv A, Kalter-leibovici O. Blood pressure level and hypertension awareness and control differ by marital status, sex, and ethnicity: a population-based study. Am J Hypertens. 2014;27:1511–20.

    Article  CAS  PubMed  Google Scholar 

  44. Eghbali M, Khosravi A, Feizi A, Mansouri A, Mahaki B. Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran. Epidemiol Heal. 2018;40:1–9.

    Google Scholar 

  45. Saka M, Shabu S, Shabila N. Prevalence of hypertension and associated risk factors in older adults in Kurdistan, Iraq. East Mediterr Heal J. 2020;26:265–72.

    Google Scholar 

  46. El-reshaid K, Al-owaish R, Diab A. Hypertension in Kuwait: the past, present and future. Saudi J Kidney Dis Transpl. 1999;10:357–64.

    CAS  PubMed  Google Scholar 

  47. Al Riyami AA, Afifi M. Clustering of cardiovascular risk factors among Omani adults. East Mediterr Heal J. 2003;9:893–903.

    Article  Google Scholar 

  48. Gupta R, Gupta V, Sarna M, Bhatnagar S, Thanvi J, Sharma V, Singh A, Gupta J, Kaul V. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2. Indian Heart J. 2002;54:59–66.

    PubMed  Google Scholar 

  49. Mohan V, Deepa R, Shanthi Rani S, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: the Chennai Urban Population Study (CUPS no. 5). J Am Coll Cardiol. 2001;38:682–7.

    Article  CAS  PubMed  Google Scholar 

  50. Gupta PC, Gupta R. Hypertension prevalence and blood pressure trends among 99,589 subjects in Mumbai, India. Indian Heart J. 1999;51:691.

    Google Scholar 

  51. Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, Prabhakaran D. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32:1170–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Rezvi Sheriff MH, Matthews DR. The prevalence, predictors and associations of hypertension in Sri Lanka: a cross-sectional population based national survey. Clin Exp Hypertens. 2014;36:484–91.

    Article  PubMed  Google Scholar 

  53. Islam JY, Zaman MM, Haq SA, Ahmed S, Al- Quadir Z. Epidemiology of hypertension among Bangladeshi adults using the 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Joint National Committee 7 Guidelines. J Hum Hypertens. 2018;32:668–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Hasan M, Khan MSA, Sutradhar I, Hossain MM, Hossaine M, Yoshimura Y, Choudhury SR, Sarker M, Mridha MK. Prevalence and associated factors of hypertension in selected urban and rural areas of Dhaka, Bangladesh: findings from SHASTO baseline survey. BMJ Open. 2021;11:1–12.

    Article  Google Scholar 

  55. Jafar TH, Levey AS, Jafary FH, White F, Gul A, Rahbar MH, Khan AQ, Hattersley A, Schmid CH, Chaturvedi N. Ethnic subgroup differences in hypertension in Pakistan. J Hypertens. 2003;21:905–12.

    Article  CAS  PubMed  Google Scholar 

  56. Prajapati D, Poudel P, Hirachan A, et al. Prevalence and determinants of systemic hypertension in inhabitants of high altitude of Nepal. Asian J Med Sci. 2020;11:12–6.

    Article  Google Scholar 

  57. Karmacharya BM, Koju RP, LoGerfo JP, Chan KCG, Mokdad AH, Shrestha A, Sotoodehnia N, Fitzpatrick AL. Awareness, treatment and control of hypertension in Nepal: findings from the Dhulikhel Heart Study. Heart Asia. 2017;9:1–8.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Aboobakur M, Latheef A, Mohamed AJ, Moosa S, Pandey RM, Krishnan A, Prabhakaran D. Surveillance for non-communicable disease risk factors in Maldives: results from the first STEPS survey in Male. Int J Public Health. 2010;55:489–96.

    Article  PubMed  Google Scholar 

  59. Lupat A, Hengelbrock J, Luissin M, Fix M, Bassa B, Craemer EM, Becher H, Meyding-Lamadé U. Brunei epidemiological stroke study: patterns of hypertension and stroke risk. J Hypertens. 2016;34:1416–22.

    Article  CAS  PubMed  Google Scholar 

  60. Gupta V, LoGerfo JP, Raingsey PP, Fitzpatrick AL. The prevalence and associated factors for prehypertension and hypertension in Cambodia. Heart Asia. 2013;5:253–8.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Peltzer K, Pengpid S. The prevalence and social determinants of hypertension among adults in Indonesia: a cross-sectional population-based national survey. Int J Hypertens. 2018;2018:5610725. https://doi.org/10.1155/2018/5610725.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Christiani Y, Byles JE, Tavener M, Dugdale P. Gender inequalities in noncommunicable disease risk factors among Indonesian urban population. Asia-Pacific J Public Heal. 2016;28:134–45.

    Article  Google Scholar 

  63. Committee S, D CPM, D IBM, Investigator P, Officer T. Report on STEPS survey on non communicable diseases risk factors in Vientiane Capital city, Lao PDR; 2010.

    Google Scholar 

  64. Ab Majid NL, Omar MA, Khoo YY, Mahadir Naidu B, Ling Miaw Yn J, Rodzlan Hasani WS, Mat Rifin H, Abd Hamid HA, Robert Lourdes TG, Mohd Yusoff MF. Prevalence, awareness, treatment and control of hypertension in the Malaysian population: findings from the National Health and Morbidity Survey 2006–2015. J Hum Hypertens. 2018;32:617–24.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Abdul-Razak S, Daher AM, Ramli AS, et al. Prevalence, awareness, treatment, control and socio demographic determinants of hypertension in Malaysian adults. BMC Public Health. 2016;16:1–10.

    Article  Google Scholar 

  66. Bjertness MB, Htet AS, Meyer HE, Htike MMT, Zaw KK, Oo WM, Latt TS, Sherpa LY, Bjertness E. Prevalence and determinants of hypertension in Myanmar—a nationwide cross-sectional study. BMC Public Health. 2016;16:590. https://doi.org/10.1186/s12889-016-3275-7.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Ministry of Health. Executive summary on national population health survey 2016/17; 2017. p. 1–4.

    Google Scholar 

  68. Liew SJ, Lee JT, Tan CS, Koh CHG, Van Dam R, Müller-Riemenschneider F. Sociodemographic factors in relation to hypertension prevalence, awareness, treatment and control in a multi-ethnic Asian population: a cross-sectional study. BMJ Open. 2019;9:1–10.

    Article  Google Scholar 

  69. Tiptaradol S, Aekplakorn W. Prevalence, awareness, treatment and control of coexistence of diabetes and hypertension in Thai population. Int J Hypertens. 2012;2012:386453. https://doi.org/10.1155/2012/386453.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Son PT, Quang NN, Viet NL, Khai PG, Wall S, Weinehall L, Bonita R, Byass P. Prevalence, awareness, treatment and control of hypertension in Vietnamresults from a national survey. J Hum Hypertens. 2012;26:268–80.

    Article  CAS  PubMed  Google Scholar 

  71. Meiqari L, Essink D, Wright P, Scheele F. Prevalence of hypertension in Vietnam: a systematic review and meta-analysis. Asia-Pacific J Public Heal. 2019;31:101–12.

    Article  Google Scholar 

  72. Patalen C. Expanded National Nutrition Survey: 2019 results health and nutritional status of Filipino adults, 20–59 years old; 2019. p. 20–59.

    Google Scholar 

  73. Sison J. Presyon 3; 2013.

    Google Scholar 

  74. World Health Organization (WHO). High blood pressure—country experiences and effective interventions utilized across the European Region. World Health Organization; 2013. p. 1–30.

    Google Scholar 

  75. Gupta R, Gaur K, Ram CVS. Emerging trends in hypertension epidemiology in India. J Hum Hypertens. 2019;33(8):575–87.

    Article  CAS  PubMed  Google Scholar 

  76. Oliva RV. A review on the status of hypertension in six Southeast Asian countries. Hypertens J. 2019;5:5–8.

    Article  Google Scholar 

  77. Castillo R. Prevalence and management of hypertension in Southeast Asia; 2016:2016.

    Google Scholar 

  78. Xing L, Liu S, Jing L, et al. Trends in prevalence, awareness, treatment, and control of hypertension in rural Northeast China: 2008 to 2018. Biomed Res Int. 2020;2020:1456720. https://doi.org/10.1155/2020/1456720.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Thawornchaisit P, De Looze F, Reid CM, Seubsman S, Sleigh AC, Cohort T, Team S. Health risk factors and the incidence of hypertension: 4-year prospective findings from a national cohort of 60 569 Thai Open University students. BMJ Open. 2013;3(6):e002826. https://doi.org/10.1136/bmjopen-2013-002826.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Asgari S, Moazzeni SS, Azizi F, Abdi H, Khalili D, Hakemi MS, Hadaegh F. Sex-specific incidence rates and risk factors for hypertension during 13 years of follow-up: the Tehran Lipid and Glucose Study. Glob Heart. 2020;15:1–13.

    Google Scholar 

  81. Talaei M, Sadeghi M, Mohammadifard N, Shokouh P, Oveisgharan S, Sarrafzadegan N. Incident hypertension and its predictors: the Isfahan Cohort Study. J Hypertens. 2014;32(1):30–38.

    Google Scholar 

  82. Mohan V, Anjana RM, Unnikrishnan R. Incidence of hypertension among Asian Indians: 10 year follow up of the Chennai Urban Rural Epidemiology Study (CURES-153). J Diabetes Complicat. 2020;34(10):107652.

    Article  Google Scholar 

  83. Prabhakaran D, Jeemon P, Ghosh S, Shivashankar R, Ajay VS, Kondal D, Gupta R, Ali MK, Mohan D, Mohan V, Kadir MM, Tandon N, Reddy KS, Venkat Narayan KM. Prevalence and incidence of hypertension: results from a representative cohort of over 16,000 adults in three cities of South Asia. Indian Heart J. 2017;69(4):434–41. https://doi.org/10.1016/j.ihj.2017.05.021.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Luo Y, Xia F, Yu X, Li P, Huang W. Long-term trends and regional variations of hypertension incidence in China: a prospective cohort study from the China Health and Nutrition Survey, 1991–2015. BMJ Open. 2021;11:1–9.

    Article  CAS  Google Scholar 

  85. Yu ES, Hong K, Chun BC. A longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: a 12-year Korean cohort. BMC Public Health. 2021;21(1):61.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Oka M, Yamamoto M, Mure K, Takeshita T, Arita M. Relationships between lifestyle, living environments, and incidence of hypertension in Japan (in men): based on participant’s data from the nationwide medical check-up. PLoS One. 2016;11:1–9.

    Article  Google Scholar 

  87. Sy RG. Hypertension among apparently healthy adult Filipinos in the LIFECARE Philippine cohort.

    Google Scholar 

  88. Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, Mcalister FA, Johansen H, Baclic O, Campbell N. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3(8):e003423.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Dhar L, Dantas J, Ali M. A systematic review of factors influencing medication adherence to hypertension treatment in developing countries. Open J Epidemiol. 2017;7:211–50.

    Article  Google Scholar 

  90. Division E and DC. National Health Survey 2010; 2010. Singapore.

    Google Scholar 

  91. Sison J, Arceo LP, Buan N, Reynaldo E, Torres DJ, Trinidad E, Chua P, Punzalan A, Yape IM, Bautista A, Lapitan R. Philippine Heart Association-Council on Hypertension Report on Survey of Hypertension and Target Organ Damage (PRESYON 2-TOD*): a report on prevalence of hypertension, awareness, treatment profile and control rate. Philipp J Cardiol. 2007;35:1–9.

    Google Scholar 

  92. Wander GS, Ram CVS. Blood pressure—methods to record & numbers that are significant: lets make a tailored suit to suit us. Indian J Med Res. 2018:435–8.

    Google Scholar 

  93. Xing L, Jing L, Tian Y, et al. Urban-Rural disparities in status of hypertension in northeast China: a populationbased study, 2017-2019. Clin Epidemiol. 2019;11:801–820. Published 2019 Sep 3. https://doi.org/10.2147/CLEP.S218110.

  94. Kim K, Ji E, Choi J, Kim S, Ahn S. Ten-year trends of hypertension treatment and control rate in Korea. Sci Rep. 2021;11:6966.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  95. Kaddumukasa M, Kayima J, Nakibuuka J, Blixen C, Welter E, Katabira E, Sajatovic M. Modifiable lifestyle risk factors for stroke among a high risk hypertensive population in Greater Kampala , Uganda; a cross-sectional study. BMC Res Notes. 2017;10:675.

    Article  PubMed  PubMed Central  Google Scholar 

  96. World Health Organization (WHO). Sodium intake and iodized salt in the South-East Asia Region; 2014. p. 29–30.

    Google Scholar 

  97. Lin Y, Mei Q, Qian X, He T. Salt consumption and the risk of chronic diseases among Chinese adults in Ningbo city. Nutr J. 2020;19:1–10.

    Article  CAS  Google Scholar 

  98. Chiang C, Wang T, Ueng K, et al. Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension. J Chinese Med Assoc. 2015;78:1–47.

    Article  Google Scholar 

  99. Visanuyothin S, Plianbangchang S, Somrongthong R. Appearance and potential predictors of poorly controlled hypertension at the primary care level in an urban community. J Multidiscip Healthc. 2017;11:131–8.

    Article  Google Scholar 

  100. Wang Y, Chen J, Wang K, Edwards C. Education as an important risk factor for the prevalence of hypertension and elevated blood pressure in Chinese men and women. J Hum Hypertens. 2006;20:898–900.

    Article  CAS  PubMed  Google Scholar 

  101. Olack B, Wabwire-mangen F, Smeeth L, Montgomery JM, Kiwanuka N, Breiman RF. Risk factors of hypertension among adults aged 35–64 years living in an urban slum Nairobi, Kenya. BMC Public Health. 2015;15:1251.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Wang J, Ma JJ, Liu J, Zeng DD, Song C, Cao Z. Prevalence and risk factors of comorbidities among hypertensive patients in China. Int J Med Sci. 2017;14:201–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Tian S, Dong G, Wang D, Liu M, Lin Q, Meng X, Xu L, Hou H, Ren Y. Factors associated with prevalence, awareness, treatment and control of hypertension in urban adults from 33 communities in China: the CHPSNE Study. Hypertens Res. 2011;34:1087–92.

    Article  PubMed  Google Scholar 

  104. Shen Y, Chang C, Zhang J, Jiang Y, Ni B, Wang Y. Prevalence and risk factors associated with hypertension and prehypertension in a working population at high altitude in China: a cross-sectional study. Environ Health Prev Med. 2017;22:1–8.

    Article  Google Scholar 

  105. Leung LCK, Sung RYT, So H, et al. Prevalence and risk factors for hypertension in Hong Kong Chinese adolescents: waist circumference predicts hypertension, exercise decreases risk. Arch Dis Child. 2011;96:804–9.

    Article  PubMed  Google Scholar 

  106. Hu L, Huang X, You C, Li J, Hong K, Li P, Wu Y. Prevalence and risk factors of prehypertension and hypertension in Southern China. PLoS One. 2017;12:1–15.

    Google Scholar 

  107. Kalani Z, Salimi T, Rafiei M. Comparison of obesity indexes BMI, WHR and WC in association with hypertension: results from a Blood Pressure Status Survey in Iran. J Cardiovasc Dis Res. 2015;6:72–7.

    Article  Google Scholar 

  108. Ministry of Health Indonesia. Indonesia Health Profile 2019; 2019.

    Google Scholar 

  109. Yu ES, Hong K, Chun BC. Incidence and risk factors for progression from prehypertension to hypertension: a 12-year Korean Cohort Study. J Hypertens. 2020;38:1755–62.

    Article  CAS  PubMed  Google Scholar 

  110. Neupane D, McLachlan CS, Sharma R, Gyawali B, Khanal V, Mishra SR, Christensen B, Kallestrup P. Prevalence of hypertension in member countries of South Asian Association for Regional Cooperation (SAARC): systematic review and meta-analysis. Med (United States). 2014;93:1–10.

    Google Scholar 

  111. Motlagh B, O’Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the middle east: a systematic review. Eur J Cardiovasc Prev Rehabil. 2009;16:268–80.

    Article  PubMed  Google Scholar 

  112. Liu F, Liu Y, Sun X, et al. Nutrition, metabolism & cardiovascular diseases race- and sex-specific association between alcohol consumption and hypertension in 22 cohort studies: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2020;30(8):1249–59. https://doi.org/10.1016/j.numecd.2020.03.018.

    Article  CAS  PubMed  Google Scholar 

  113. Roerecke M, Kaczorowski J, Tobe SW, Gmel G, Hasan OSM, Rehm J. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Heal. 2017;2:e108–20.

    Article  Google Scholar 

  114. Naing C, Aung K. Prevalence and risk factors of hypertension in Myanmar: a systematic review and meta-analysis. Med (United States). 2014;93:1–9.

    Google Scholar 

  115. World Health Organization (WHO). Global health risks: mortality and burden of disease attributable to selected major risks; 2009.

    Google Scholar 

  116. Cleven L, Krell-roesch J, Nigg CR, Woll A. The association between physical activity with incident obesity, coronary heart disease, diabetes and hypertension in adults: a systematic review of longitudinal studies published after 2012. BMC Public Health. 2020;20:1–15.

    Article  Google Scholar 

  117. Ranasinghe CD, Ranasinghe P, Jayawardena R, Misra A. Physical activity patterns among South-Asian adults: a systematic review. Int J Behav Nutr Phys Act. 2013;10:1–11.

    Article  Google Scholar 

  118. Zhang Y, Fan X, Li S, Wang Y, Shi S, Lu H, Yan F. Prevalence and risk factors of hypertension among Hui population in China. Medicine (Baltimore). 2021;100(18):e25192.

    Article  CAS  Google Scholar 

  119. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, Singh GM. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 30 million participants. Lancet. 2011;377:578–86.

    Article  PubMed  Google Scholar 

  120. Joshi P. Risk factors for early myocardial infarction in South Asians compared with individuals. J Am Med Assoc. 2015;297:286–94.

    Article  Google Scholar 

  121. Rehman H, Samad Z, Raj S, Merchant AT, Narula JP, Mishra S, Virani SS, Asia S. Epidemiologic studies targeting primary cardiovascular disease prevention in South Asia. Indian Heart J. 2018;70(5):721–30. https://doi.org/10.1016/j.ihj.2018.01.029.

    Article  PubMed  PubMed Central  Google Scholar 

  122. Fujiyoshi A, Ohkubo T, Miura K, Murakami Y, Nagasawa S. Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res. 2012;35:947–53.

    Article  PubMed  Google Scholar 

  123. Wierzejska E, Giernaś B, Lipiak A, Karasiewicz M, Cofta M. Systematic review/meta-analysis. A global perspective on the costs of hypertension: a systematic review. Arch Med Sci. 2020;16:1078–91.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Medicine, Department of Medicine, Philippine General Hospital, University of the Philippines, Manila, Philippines

    Rody G. Sy, Elmer Jasper B. Llanes, Felix Eduardo R. Punzalan, Jaime Alfonso M. Aherrera & Paula Victoria Catherine Y. Cheng

Authors
  1. Rody G. Sy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elmer Jasper B. Llanes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Felix Eduardo R. Punzalan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jaime Alfonso M. Aherrera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paula Victoria Catherine Y. Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Apollo Hospitals, Apollo Institute for Blood Pressure Management, Hyderabad, India

    C. Venkata S. Ram

  2. Head, Division of Nephrology Department of Medicine, Yong Loo Lin Sch of Med Natl Univ of Sin, Singapore, Singapore

    Boon Wee Jimmy Teo

  3. Department of Cardiology, Hero DMC Heart Institute, Dayanand Medical College, Ludhiana, Punjab, India

    Gurpreet S. Wander

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sy, R.G., Llanes, E.J.B., Punzalan, F.E.R., Aherrera, J.A.M., Cheng, P.V.C.Y. (2022). Epidemiology of Hypertension in Asia. In: Ram, C.V.S., Teo, B.W.J., Wander, G.S. (eds) Hypertension and Cardiovascular Disease in Asia. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-030-95734-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-95734-6_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-95733-9

  • Online ISBN: 978-3-030-95734-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation